Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists uncover new DNA role in modifying gene function

11.04.2011
Findings suggest new approach could create highly targeted therapeutics

For years, scientists have thought of DNA as a passive blueprint capable only of producing specific proteins through RNA transcription. Now, research led by scientists from the Florida campus of The Scripps Research Institute has shown DNA can also act to fine-tune the activity of certain proteins known as nuclear receptors.

These new findings may make it possible to design therapies that could activate specific genes in a highly targeted manner in a number of important diseases including osteoporosis, obesity, autoimmune disease, and cancer.

The study was published April 10, 2011, in the journal Nature Structural & Molecular Biology.

"This study offers the first direct evidence of what we now recognize as critically important interactions," said team leader Patrick R. Griffin, PhD, chair of the Department of Molecular Therapeutics and director of the Translational Research Institute at Scripps Florida. "This new understanding could lead to the development of ways to promote highly targeted activity, which is exactly what you need in order to produce safe and effective therapies."

The new study focuses on the interactions between a protein complex comprising the vitamin D receptor and the retinoic X receptor and their ligands, vitamin D and 9-cis-retinoic acid (a metabolite of vitamin A), respectively, as well as DNA, and a coregulatory protein. Receptors are proteins to which one or more specific kinds of signaling molecules bind.

Scientists at Eli Lilly and Company collaborated on this study to better understand how vitamin D works at its most basic level, given that vitamin D plays a major role in bone health and is thus linked to the company's research platform in osteoporosis.

"These findings will potentially enable us to design safer medicines that work via the vitamin D pathway to help the osteoporotic patient," said Jeffrey A. Dodge, PhD, senior research fellow at Lilly. "Specifically, the technology developed at Scripps to understand these receptor ligand interactions has been critical and is a great example of industry-academia collaboration to solve important scientific questions."

Dynamic Interactions

In the new study, the scientists used a technology known as hydrogen-deuterium exchange (HDX) mass spectrometry to measure the interaction of various ligands with the vitamin D receptor complex. Ligands can be small synthetic compounds, hormones, other proteins, or DNA and they bind to large molecules such as proteins and change these molecules' behavior. In this study, the ligands were vitamin D, a metabolite of vitamin A, DNA, and a coactivator protein known as SRC1 (steroid receptor coactivator 1).

"HDX mass spectrometry is a high-precision, high-sensitivity mapping technique," Griffin explained. "With it, we can find the specific regions of the protein complex that are altered upon interaction with ligand. This information can be used to infer structural changes that are the result of a specific interaction."

In their research, the scientists found that DNA can actually alter the structure and function of the receptor complex through a wide variety of long-range structural effects. These long-range effects had been hypothesized, but this study is the first to actually detect them directly with high spatial resolution. The changes wrought by these dynamic interactions were impressive.

The study shows these binding events have substantial consequences; for example, that the DNA binding at one site alters the stability of both the ligand binding site as well as coactivator interaction surface at opposite ends of the complex and vice versa. Those alterations influence a number of key processes, from coactivator-mediated interactions with various cofactors to the modification of the DNA binding domain so that the receptor can recognize specific DNA sequences.

"There is an elaborate biochemical dialogue going on between the receptor, ligand, coregulatory proteins, and the specific DNA sequence that the nuclear receptor complex is bound to," said Griffin. "But until this study, it was not completely clear what the structural basis for this crosstalk was."

The first author of the study, "DNA Binding Alters Coactivator Interaction Surfaces of the Intact VDR/RXR Complex," is Jun Zhang of Scripps Research. In addition to Griffin, other authors include Michael J. Chalmers, Yongjun Wang, Scott A. Busby, Bruce D. Pascal, Ruben D Garcia-Ordonez, and Thomas P. Burris of Scripps Research; Keith R. Stayrook, Lorri L. Burris, and Jeffrey A. Dodge of Lilly Research Laboratories; and John B. Bruning of Texas A&M University.

The study was supported by the National Institutes of Health.

About The Scripps Research Institute

The Scripps Research Institute is one of the world's largest independent, non-profit biomedical research organizations, at the forefront of basic biomedical science that seeks to comprehend the most fundamental processes of life. Scripps Research is internationally recognized for its discoveries in immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune, cardiovascular, and infectious diseases, and synthetic vaccine development. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, Scripps Research currently employs approximately 3,000 scientists, postdoctoral fellows, scientific and other technicians, doctoral degree graduate students, and administrative and technical support personnel. Headquartered in La Jolla, California, the institute also includes Scripps Florida, whose researchers focus on basic biomedical science, drug discovery, and technology development. Scripps Florida is located in Jupiter, Florida. For more information, see www.scripps.edu .

Mika Ono | EurekAlert!
Further information:
http://www.scripps.edu

More articles from Life Sciences:

nachricht Bare bones: Making bones transparent
27.04.2017 | California Institute of Technology

nachricht Link Discovered between Immune System, Brain Structure and Memory
26.04.2017 | Universität Basel

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

Bare bones: Making bones transparent

27.04.2017 | Life Sciences

Study offers new theoretical approach to describing non-equilibrium phase transitions

27.04.2017 | Physics and Astronomy

From volcano's slope, NASA instrument looks sky high and to the future

27.04.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>